Aarti Pharmalabs Ltd.
BSE: 543748 | NSE: AARTIPHARM
Small Cap | Pharmaceuticals & Drugs
706.15
7.40 (1.06%) Aarti Pharmalabs - Quaterly Results
Date: 07-11-2023
A decrease in the sales to Rs. 3561.40 millions was observed for the quarter ended September 2023. The sales stood at Rs. 4045.00 millions during the similar quarter previous year.The Net Profit of the company registered a slight decline of -8.97% to Rs. 418.10 millions from Rs. 459.30 millions.The company reported a degrowth in operating Profit to 738.00 millions from 815.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202309 | 202209 | % Var | 202309 | 202209 | % Var | 202303 | 202203 | % Var | |
| Sales | 3561.40 | 4045.00 | -11.96 | 7142.80 | 7776.50 | -8.15 | 15112.50 | 9410.20 | 60.60 |
| Other Income | 0.00 | 12.40 | 0.00 | 48.60 | 12.40 | 291.94 | 12.80 | 25.10 | -49.00 |
| PBIDT | 738.00 | 815.00 | -9.45 | 1554.00 | 1602.10 | -3.00 | 3096.20 | 1822.90 | 69.85 |
| Interest | 38.20 | 55.20 | -30.80 | 78.50 | 95.70 | -17.97 | 204.90 | 113.40 | 80.69 |
| PBDT | 699.80 | 759.80 | -7.90 | 1475.50 | 1506.40 | -2.05 | 2891.30 | 1709.50 | 69.13 |
| Depreciation | 163.20 | 145.50 | 12.16 | 317.60 | 269.60 | 17.80 | 557.70 | 372.30 | 49.80 |
| PBT | 536.60 | 614.30 | -12.65 | 1157.90 | 1236.80 | -6.38 | 2333.60 | 1337.20 | 74.51 |
| TAX | 118.50 | 155.00 | -23.55 | 263.50 | 305.00 | -13.61 | 616.30 | 270.00 | 128.26 |
| Deferred Tax | 15.00 | 22.50 | -33.33 | 50.00 | 45.00 | 11.11 | 95.00 | 45.00 | 111.11 |
| PAT | 418.10 | 459.30 | -8.97 | 894.40 | 931.80 | -4.01 | 1717.30 | 1067.20 | 60.92 |
| Equity | 453.10 | 453.10 | 0.00 | 453.10 | 453.10 | 0.00 | 453.10 | 455.60 | -0.55 |
| PBIDTM(%) | 20.72 | 20.15 | 2.85 | 21.76 | 20.60 | 5.60 | 20.49 | 19.37 | 5.76 |